This phosphorylation event subsequently inhibits exon 10 skipping in METTL14, resulting in an up‐regulation of the METTL14‐Lexon10+ variant and a down‐regulation of the METTL14‐Lexon10− variant in pancreatic cancer.141. Here, METTL14 is linked to pancreatic neoplasm.